University of Utah fatigue researchers Kathleen Light, PhD, and Alan Light, PhD have received a $1 million, 3-year research grant from the National Institutes of Health.
The grant will essentially expand their work to establish solid biomarkers for CFS and CFS subgroups (e.g., CFS with orthostatic intolerance, CFS with FM), as well as fibromyalgia that does not include CFS. (About 70% of their study subjects with ME/CFS reportedly also have fibromyalgia.)
See their groundbreaking report, “Gene Expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome,” published by the Journal of Internal Medicine in July. This work was funded by previous smaller NIH grants, the CFIDS Association of America, and the American Fibromyalgia Syndrome Association.
Working as clinical partners of Salt Lake City-based fatigue specialist Lucinda Bateman, MD, Kathleen Light has said the goal of their work is a marketable diagnostic test, offered via a new start-up company, that physicians can use to differentiate CFS patients and subgroups from people fatigued for other reasons, such as depression or cancer.
Source: Daily Utah Chronicle, Sep 21, “National Institutes of Health funds $1 million study on fatigue,” by Elaine Ball.